These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 2013809

  • 1. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate.
    Kuwabara H, Gjedde A.
    J Nucl Med; 1991 Apr; 32(4):692-8. PubMed ID: 2013809
    [Abstract] [Full Text] [Related]

  • 2. Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose.
    Kuwabara H, Evans AC, Gjedde A.
    J Cereb Blood Flow Metab; 1990 Mar; 10(2):180-9. PubMed ID: 2303534
    [Abstract] [Full Text] [Related]

  • 3. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
    Schmidt K, Lucignani G, Moresco RM, Rizzo G, Gilardi MC, Messa C, Colombo F, Fazio F, Sokoloff L.
    J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
    [Abstract] [Full Text] [Related]

  • 4. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
    Piert M, Koeppe RA, Giordani B, Berent S, Kuhl DE.
    J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
    [Abstract] [Full Text] [Related]

  • 5. Effect of selecting a fixed dephosphorylation rate on the estimation of rate constants and rCMRGlu from dynamic [18F] fluorodeoxyglucose/PET data.
    Dhawan V, Moeller JR, Strother SC, Evans AC, Rottenberg DA.
    J Nucl Med; 1989 Sep; 30(9):1483-8. PubMed ID: 2788721
    [Abstract] [Full Text] [Related]

  • 6. Determination of 18F-fluoro-2-deoxy-D-glucose rate constants in the anesthetized baboon brain with dynamic positron tomography.
    Miyazawa H, Osmont A, Petit-Taboué MC, Tillet I, Travère JM, Young AR, Barré L, MacKenzie ET, Baron JC.
    J Neurosci Methods; 1993 Dec; 50(3):263-72. PubMed ID: 8152238
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the effect of glucose ingestion and kinetic model configurations of FDG in the normal liver.
    Choi Y, Hawkins RA, Huang SC, Brunken RC, Hoh CK, Messa C, Nitzsche EU, Phelps ME, Schelbert HR.
    J Nucl Med; 1994 May; 35(5):818-23. PubMed ID: 8176464
    [Abstract] [Full Text] [Related]

  • 8. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
    Heiss WD, Pawlik G, Herholz K, Wagner R, Göldner H, Wienhard K.
    J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
    [Abstract] [Full Text] [Related]

  • 9. Metabolic brain imaging. Direct regional measurement of transfer coefficients and lumped constant.
    Gjedde A, Kuwabara H, Evans AC.
    Acta Radiol Suppl; 1990 Jun; 374():117-21. PubMed ID: 1966957
    [Abstract] [Full Text] [Related]

  • 10. Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.
    Piert M, Koeppe RA, Giordani B, Minoshima S, Kuhl DE.
    J Nucl Med; 1996 Jul; 37(7):1115-22. PubMed ID: 8965180
    [Abstract] [Full Text] [Related]

  • 11. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
    Wienhard K, Pawlik G, Nebeling B, Rudolf J, Fink G, Hamacher K, Stöcklin G, Heiss WD.
    J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
    [Abstract] [Full Text] [Related]

  • 12. Dynamic [18F]fluorodeoxyglucose positron emission tomography and hypometabolic zones in seizures: reduced capillary influx.
    Cornford EM, Gee MN, Swartz BE, Mandelkern MA, Blahd WH, Landaw EM, Delgado-Escueta AV.
    Ann Neurol; 1998 Jun; 43(6):801-8. PubMed ID: 9629850
    [Abstract] [Full Text] [Related]

  • 13. Calculation of the FDG lumped constant by simultaneous measurements of global glucose and FDG metabolism in humans.
    Hasselbalch SG, Madsen PL, Knudsen GM, Holm S, Paulson OB.
    J Cereb Blood Flow Metab; 1998 Feb; 18(2):154-60. PubMed ID: 9469157
    [Abstract] [Full Text] [Related]

  • 14. [Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma].
    Enomoto K, Fukunaga T, Okazumi S, Asano T, Kikuchi T, Yamamoto H, Nagashima T, Isono K, Itoh H, Imazeki K.
    Kaku Igaku; 1991 Nov; 28(11):1353-6. PubMed ID: 1663176
    [Abstract] [Full Text] [Related]

  • 15. Effect of vascular activity in the determination of rate constants for the uptake of 18F-labeled 2-fluoro-2-deoxy-D-glucose: error analysis and normal values in older subjects.
    Evans AC, Diksic M, Yamamoto YL, Kato A, Dagher A, Redies C, Hakim A.
    J Cereb Blood Flow Metab; 1986 Dec; 6(6):724-38. PubMed ID: 3491827
    [Abstract] [Full Text] [Related]

  • 16. FDG transport and phosphorylation in human gliomas measured with dynamic PET.
    Herholz K, Rudolf J, Heiss WD.
    J Neurooncol; 1992 Feb; 12(2):159-65. PubMed ID: 1560262
    [Abstract] [Full Text] [Related]

  • 17. [Hemocirculation and metabolism in intraventricular tumors: kinetic analysis of glucose metabolism].
    Shioya H, Mineura K, Kowada M, Iida H, Murakami M, Ogawa T, Hatazawa J, Uemura K.
    No Shinkei Geka; 1996 Mar; 24(3):211-9. PubMed ID: 8851949
    [Abstract] [Full Text] [Related]

  • 18. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.
    Torizuka T, Tamaki N, Inokuma T, Magata Y, Sasayama S, Yonekura Y, Tanaka A, Yamaoka Y, Yamamoto K, Konishi J.
    J Nucl Med; 1995 Oct; 36(10):1811-7. PubMed ID: 7562048
    [Abstract] [Full Text] [Related]

  • 19. Assessment of the [18F]fluorodeoxyglucose kinetic model in calculations of myocardial glucose metabolism during ischemia.
    Marshall RC, Huang SC, Nash WW, Phelps ME.
    J Nucl Med; 1983 Nov; 24(11):1060-4. PubMed ID: 6631527
    [Abstract] [Full Text] [Related]

  • 20. A modeling method to improve quantitation of fluorodeoxyglucose uptake in heterogeneous tumor tissue.
    Wu HM, Huang SC, Choi Y, Hoh CK, Hawkins RA.
    J Nucl Med; 1995 Feb; 36(2):297-306. PubMed ID: 7830134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.